The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Decentralized Clinical Trial Solution Market Research Report 2025
Synopsis
A Decentralized Clinical Trial (DCT) solution refers to a method of conducting clinical trials in which traditional trial activities, such as patient recruitment, data collection, and monitoring, are conducted remotely or outside of the traditional clinical trial setting. This approach leverages technology to streamline trial processes, reduce the burden on participants, and potentially improve the efficiency and accuracy of data collection.
The global Decentralized Clinical Trial Solution market was valued at US$ 7135 million in 2023 and is anticipated to reach US$ 14520 million by 2030, witnessing a CAGR of 10.8% during the forecast period 2024-2030.
The Decentralized Clinical Trial (DCT) Solution market has witnessed significant growth in recent years, fueled by the increasing adoption of digital technologies and the need for more efficient and patient-centric trial processes. Major sales regions for DCT solutions include North America, Europe, and Asia Pacific, driven by the presence of prominent pharmaceutical and biotechnology companies, supportive regulatory environments, and growing investments in healthcare IT infrastructure. However, despite the market's rapid expansion, there remains a degree of concentration among a few key players, leading to potential challenges for smaller vendors to penetrate the market. Nonetheless, opportunities abound, particularly in developing regions where there is a growing emphasis on healthcare digitization and expanding clinical trial capabilities. Challenges such as regulatory compliance, data security, and interoperability issues persist but are being addressed through collaborations between industry stakeholders and advancements in technology. As the healthcare landscape continues to evolve, the DCT Solution market is poised for further growth, offering innovative solutions to streamline clinical trial processes and improve patient outcomes.
This report aims to provide a comprehensive presentation of the global market for Decentralized Clinical Trial Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decentralized Clinical Trial Solution.
The Decentralized Clinical Trial Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Decentralized Clinical Trial Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decentralized Clinical Trial Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ICON
Medpace
Oracle
Patheon
Medidata Solutions
IQVIA
Parexel
PPD
Science 37
Signant Health
Syneos Health
Obvio Health
Fortrea
ProPharma
Cloudbyz
Q 2 Solutions
Advarra
Medrio
Huma
THREAD
Cogstate
Veristat
Clario
Segment by Type
Hybrid Clinical Trial
Completely Decentralized Clinical Trial
Segment by Application
Oncology
Cardiovascular
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Decentralized Clinical Trial Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A Decentralized Clinical Trial (DCT) solution refers to a method of conducting clinical trials in which traditional trial activities, such as patient recruitment, data collection, and monitoring, are conducted remotely or outside of the traditional clinical trial setting. This approach leverages technology to streamline trial processes, reduce the burden on participants, and potentially improve the efficiency and accuracy of data collection.
The global Decentralized Clinical Trial Solution market was valued at US$ 7135 million in 2023 and is anticipated to reach US$ 14520 million by 2030, witnessing a CAGR of 10.8% during the forecast period 2024-2030.
The Decentralized Clinical Trial (DCT) Solution market has witnessed significant growth in recent years, fueled by the increasing adoption of digital technologies and the need for more efficient and patient-centric trial processes. Major sales regions for DCT solutions include North America, Europe, and Asia Pacific, driven by the presence of prominent pharmaceutical and biotechnology companies, supportive regulatory environments, and growing investments in healthcare IT infrastructure. However, despite the market's rapid expansion, there remains a degree of concentration among a few key players, leading to potential challenges for smaller vendors to penetrate the market. Nonetheless, opportunities abound, particularly in developing regions where there is a growing emphasis on healthcare digitization and expanding clinical trial capabilities. Challenges such as regulatory compliance, data security, and interoperability issues persist but are being addressed through collaborations between industry stakeholders and advancements in technology. As the healthcare landscape continues to evolve, the DCT Solution market is poised for further growth, offering innovative solutions to streamline clinical trial processes and improve patient outcomes.
This report aims to provide a comprehensive presentation of the global market for Decentralized Clinical Trial Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decentralized Clinical Trial Solution.
The Decentralized Clinical Trial Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Decentralized Clinical Trial Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decentralized Clinical Trial Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ICON
Medpace
Oracle
Patheon
Medidata Solutions
IQVIA
Parexel
PPD
Science 37
Signant Health
Syneos Health
Obvio Health
Fortrea
ProPharma
Cloudbyz
Q 2 Solutions
Advarra
Medrio
Huma
THREAD
Cogstate
Veristat
Clario
Segment by Type
Hybrid Clinical Trial
Completely Decentralized Clinical Trial
Segment by Application
Oncology
Cardiovascular
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Decentralized Clinical Trial Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Decentralized Clinical Trial Solution Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hybrid Clinical Trial
1.2.3 Completely Decentralized Clinical Trial
1.3 Market by Application
1.3.1 Global Decentralized Clinical Trial Solution Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Decentralized Clinical Trial Solution Market Perspective (2019-2030)
2.2 Global Decentralized Clinical Trial Solution Growth Trends by Region
2.2.1 Global Decentralized Clinical Trial Solution Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Decentralized Clinical Trial Solution Historic Market Size by Region (2019-2024)
2.2.3 Decentralized Clinical Trial Solution Forecasted Market Size by Region (2025-2030)
2.3 Decentralized Clinical Trial Solution Market Dynamics
2.3.1 Decentralized Clinical Trial Solution Industry Trends
2.3.2 Decentralized Clinical Trial Solution Market Drivers
2.3.3 Decentralized Clinical Trial Solution Market Challenges
2.3.4 Decentralized Clinical Trial Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Decentralized Clinical Trial Solution Players by Revenue
3.1.1 Global Top Decentralized Clinical Trial Solution Players by Revenue (2019-2024)
3.1.2 Global Decentralized Clinical Trial Solution Revenue Market Share by Players (2019-2024)
3.2 Global Decentralized Clinical Trial Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Decentralized Clinical Trial Solution Revenue
3.4 Global Decentralized Clinical Trial Solution Market Concentration Ratio
3.4.1 Global Decentralized Clinical Trial Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Decentralized Clinical Trial Solution Revenue in 2023
3.5 Global Key Players of Decentralized Clinical Trial Solution Head office and Area Served
3.6 Global Key Players of Decentralized Clinical Trial Solution, Product and Application
3.7 Global Key Players of Decentralized Clinical Trial Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Decentralized Clinical Trial Solution Breakdown Data by Type
4.1 Global Decentralized Clinical Trial Solution Historic Market Size by Type (2019-2024)
4.2 Global Decentralized Clinical Trial Solution Forecasted Market Size by Type (2025-2030)
5 Decentralized Clinical Trial Solution Breakdown Data by Application
5.1 Global Decentralized Clinical Trial Solution Historic Market Size by Application (2019-2024)
5.2 Global Decentralized Clinical Trial Solution Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Decentralized Clinical Trial Solution Market Size (2019-2030)
6.2 North America Decentralized Clinical Trial Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Decentralized Clinical Trial Solution Market Size by Country (2019-2024)
6.4 North America Decentralized Clinical Trial Solution Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Decentralized Clinical Trial Solution Market Size (2019-2030)
7.2 Europe Decentralized Clinical Trial Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Decentralized Clinical Trial Solution Market Size by Country (2019-2024)
7.4 Europe Decentralized Clinical Trial Solution Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Decentralized Clinical Trial Solution Market Size (2019-2030)
8.2 Asia-Pacific Decentralized Clinical Trial Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Decentralized Clinical Trial Solution Market Size by Region (2019-2024)
8.4 Asia-Pacific Decentralized Clinical Trial Solution Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Decentralized Clinical Trial Solution Market Size (2019-2030)
9.2 Latin America Decentralized Clinical Trial Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Decentralized Clinical Trial Solution Market Size by Country (2019-2024)
9.4 Latin America Decentralized Clinical Trial Solution Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Decentralized Clinical Trial Solution Market Size (2019-2030)
10.2 Middle East & Africa Decentralized Clinical Trial Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Decentralized Clinical Trial Solution Market Size by Country (2019-2024)
10.4 Middle East & Africa Decentralized Clinical Trial Solution Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICON
11.1.1 ICON Company Details
11.1.2 ICON Business Overview
11.1.3 ICON Decentralized Clinical Trial Solution Introduction
11.1.4 ICON Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.1.5 ICON Recent Development
11.2 Medpace
11.2.1 Medpace Company Details
11.2.2 Medpace Business Overview
11.2.3 Medpace Decentralized Clinical Trial Solution Introduction
11.2.4 Medpace Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.2.5 Medpace Recent Development
11.3 Oracle
11.3.1 Oracle Company Details
11.3.2 Oracle Business Overview
11.3.3 Oracle Decentralized Clinical Trial Solution Introduction
11.3.4 Oracle Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.3.5 Oracle Recent Development
11.4 Patheon
11.4.1 Patheon Company Details
11.4.2 Patheon Business Overview
11.4.3 Patheon Decentralized Clinical Trial Solution Introduction
11.4.4 Patheon Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.4.5 Patheon Recent Development
11.5 Medidata Solutions
11.5.1 Medidata Solutions Company Details
11.5.2 Medidata Solutions Business Overview
11.5.3 Medidata Solutions Decentralized Clinical Trial Solution Introduction
11.5.4 Medidata Solutions Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.5.5 Medidata Solutions Recent Development
11.6 IQVIA
11.6.1 IQVIA Company Details
11.6.2 IQVIA Business Overview
11.6.3 IQVIA Decentralized Clinical Trial Solution Introduction
11.6.4 IQVIA Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.6.5 IQVIA Recent Development
11.7 Parexel
11.7.1 Parexel Company Details
11.7.2 Parexel Business Overview
11.7.3 Parexel Decentralized Clinical Trial Solution Introduction
11.7.4 Parexel Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.7.5 Parexel Recent Development
11.8 PPD
11.8.1 PPD Company Details
11.8.2 PPD Business Overview
11.8.3 PPD Decentralized Clinical Trial Solution Introduction
11.8.4 PPD Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.8.5 PPD Recent Development
11.9 Science 37
11.9.1 Science 37 Company Details
11.9.2 Science 37 Business Overview
11.9.3 Science 37 Decentralized Clinical Trial Solution Introduction
11.9.4 Science 37 Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.9.5 Science 37 Recent Development
11.10 Signant Health
11.10.1 Signant Health Company Details
11.10.2 Signant Health Business Overview
11.10.3 Signant Health Decentralized Clinical Trial Solution Introduction
11.10.4 Signant Health Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.10.5 Signant Health Recent Development
11.11 Syneos Health
11.11.1 Syneos Health Company Details
11.11.2 Syneos Health Business Overview
11.11.3 Syneos Health Decentralized Clinical Trial Solution Introduction
11.11.4 Syneos Health Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.11.5 Syneos Health Recent Development
11.12 Obvio Health
11.12.1 Obvio Health Company Details
11.12.2 Obvio Health Business Overview
11.12.3 Obvio Health Decentralized Clinical Trial Solution Introduction
11.12.4 Obvio Health Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.12.5 Obvio Health Recent Development
11.13 Fortrea
11.13.1 Fortrea Company Details
11.13.2 Fortrea Business Overview
11.13.3 Fortrea Decentralized Clinical Trial Solution Introduction
11.13.4 Fortrea Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.13.5 Fortrea Recent Development
11.14 ProPharma
11.14.1 ProPharma Company Details
11.14.2 ProPharma Business Overview
11.14.3 ProPharma Decentralized Clinical Trial Solution Introduction
11.14.4 ProPharma Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.14.5 ProPharma Recent Development
11.15 Cloudbyz
11.15.1 Cloudbyz Company Details
11.15.2 Cloudbyz Business Overview
11.15.3 Cloudbyz Decentralized Clinical Trial Solution Introduction
11.15.4 Cloudbyz Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.15.5 Cloudbyz Recent Development
11.16 Q 2 Solutions
11.16.1 Q 2 Solutions Company Details
11.16.2 Q 2 Solutions Business Overview
11.16.3 Q 2 Solutions Decentralized Clinical Trial Solution Introduction
11.16.4 Q 2 Solutions Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.16.5 Q 2 Solutions Recent Development
11.17 Advarra
11.17.1 Advarra Company Details
11.17.2 Advarra Business Overview
11.17.3 Advarra Decentralized Clinical Trial Solution Introduction
11.17.4 Advarra Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.17.5 Advarra Recent Development
11.18 Medrio
11.18.1 Medrio Company Details
11.18.2 Medrio Business Overview
11.18.3 Medrio Decentralized Clinical Trial Solution Introduction
11.18.4 Medrio Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.18.5 Medrio Recent Development
11.19 Huma
11.19.1 Huma Company Details
11.19.2 Huma Business Overview
11.19.3 Huma Decentralized Clinical Trial Solution Introduction
11.19.4 Huma Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.19.5 Huma Recent Development
11.20 THREAD
11.20.1 THREAD Company Details
11.20.2 THREAD Business Overview
11.20.3 THREAD Decentralized Clinical Trial Solution Introduction
11.20.4 THREAD Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.20.5 THREAD Recent Development
11.21 Cogstate
11.21.1 Cogstate Company Details
11.21.2 Cogstate Business Overview
11.21.3 Cogstate Decentralized Clinical Trial Solution Introduction
11.21.4 Cogstate Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.21.5 Cogstate Recent Development
11.22 Veristat
11.22.1 Veristat Company Details
11.22.2 Veristat Business Overview
11.22.3 Veristat Decentralized Clinical Trial Solution Introduction
11.22.4 Veristat Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.22.5 Veristat Recent Development
11.23 Clario
11.23.1 Clario Company Details
11.23.2 Clario Business Overview
11.23.3 Clario Decentralized Clinical Trial Solution Introduction
11.23.4 Clario Revenue in Decentralized Clinical Trial Solution Business (2019-2024)
11.23.5 Clario Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Decentralized Clinical Trial Solution Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hybrid Clinical Trial
Table 3. Key Players of Completely Decentralized Clinical Trial
Table 4. Global Decentralized Clinical Trial Solution Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Decentralized Clinical Trial Solution Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Decentralized Clinical Trial Solution Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Decentralized Clinical Trial Solution Market Share by Region (2019-2024)
Table 8. Global Decentralized Clinical Trial Solution Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Decentralized Clinical Trial Solution Market Share by Region (2025-2030)
Table 10. Decentralized Clinical Trial Solution Market Trends
Table 11. Decentralized Clinical Trial Solution Market Drivers
Table 12. Decentralized Clinical Trial Solution Market Challenges
Table 13. Decentralized Clinical Trial Solution Market Restraints
Table 14. Global Decentralized Clinical Trial Solution Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Decentralized Clinical Trial Solution Market Share by Players (2019-2024)
Table 16. Global Top Decentralized Clinical Trial Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trial Solution as of 2023)
Table 17. Ranking of Global Top Decentralized Clinical Trial Solution Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Decentralized Clinical Trial Solution Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Decentralized Clinical Trial Solution, Headquarters and Area Served
Table 20. Global Key Players of Decentralized Clinical Trial Solution, Product and Application
Table 21. Global Key Players of Decentralized Clinical Trial Solution, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Decentralized Clinical Trial Solution Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Decentralized Clinical Trial Solution Revenue Market Share by Type (2019-2024)
Table 25. Global Decentralized Clinical Trial Solution Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Decentralized Clinical Trial Solution Revenue Market Share by Type (2025-2030)
Table 27. Global Decentralized Clinical Trial Solution Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Decentralized Clinical Trial Solution Revenue Market Share by Application (2019-2024)
Table 29. Global Decentralized Clinical Trial Solution Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Decentralized Clinical Trial Solution Revenue Market Share by Application (2025-2030)
Table 31. North America Decentralized Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Decentralized Clinical Trial Solution Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Decentralized Clinical Trial Solution Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Decentralized Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Decentralized Clinical Trial Solution Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Decentralized Clinical Trial Solution Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Decentralized Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Decentralized Clinical Trial Solution Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Decentralized Clinical Trial Solution Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Decentralized Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Decentralized Clinical Trial Solution Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Decentralized Clinical Trial Solution Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Decentralized Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Decentralized Clinical Trial Solution Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Decentralized Clinical Trial Solution Market Size by Country (2025-2030) & (US$ Million)
Table 46. ICON Company Details
Table 47. ICON Business Overview
Table 48. ICON Decentralized Clinical Trial Solution Product
Table 49. ICON Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 50. ICON Recent Development
Table 51. Medpace Company Details
Table 52. Medpace Business Overview
Table 53. Medpace Decentralized Clinical Trial Solution Product
Table 54. Medpace Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 55. Medpace Recent Development
Table 56. Oracle Company Details
Table 57. Oracle Business Overview
Table 58. Oracle Decentralized Clinical Trial Solution Product
Table 59. Oracle Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 60. Oracle Recent Development
Table 61. Patheon Company Details
Table 62. Patheon Business Overview
Table 63. Patheon Decentralized Clinical Trial Solution Product
Table 64. Patheon Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 65. Patheon Recent Development
Table 66. Medidata Solutions Company Details
Table 67. Medidata Solutions Business Overview
Table 68. Medidata Solutions Decentralized Clinical Trial Solution Product
Table 69. Medidata Solutions Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 70. Medidata Solutions Recent Development
Table 71. IQVIA Company Details
Table 72. IQVIA Business Overview
Table 73. IQVIA Decentralized Clinical Trial Solution Product
Table 74. IQVIA Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 75. IQVIA Recent Development
Table 76. Parexel Company Details
Table 77. Parexel Business Overview
Table 78. Parexel Decentralized Clinical Trial Solution Product
Table 79. Parexel Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 80. Parexel Recent Development
Table 81. PPD Company Details
Table 82. PPD Business Overview
Table 83. PPD Decentralized Clinical Trial Solution Product
Table 84. PPD Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 85. PPD Recent Development
Table 86. Science 37 Company Details
Table 87. Science 37 Business Overview
Table 88. Science 37 Decentralized Clinical Trial Solution Product
Table 89. Science 37 Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 90. Science 37 Recent Development
Table 91. Signant Health Company Details
Table 92. Signant Health Business Overview
Table 93. Signant Health Decentralized Clinical Trial Solution Product
Table 94. Signant Health Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 95. Signant Health Recent Development
Table 96. Syneos Health Company Details
Table 97. Syneos Health Business Overview
Table 98. Syneos Health Decentralized Clinical Trial Solution Product
Table 99. Syneos Health Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 100. Syneos Health Recent Development
Table 101. Obvio Health Company Details
Table 102. Obvio Health Business Overview
Table 103. Obvio Health Decentralized Clinical Trial Solution Product
Table 104. Obvio Health Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 105. Obvio Health Recent Development
Table 106. Fortrea Company Details
Table 107. Fortrea Business Overview
Table 108. Fortrea Decentralized Clinical Trial Solution Product
Table 109. Fortrea Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 110. Fortrea Recent Development
Table 111. ProPharma Company Details
Table 112. ProPharma Business Overview
Table 113. ProPharma Decentralized Clinical Trial Solution Product
Table 114. ProPharma Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 115. ProPharma Recent Development
Table 116. Cloudbyz Company Details
Table 117. Cloudbyz Business Overview
Table 118. Cloudbyz Decentralized Clinical Trial Solution Product
Table 119. Cloudbyz Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 120. Cloudbyz Recent Development
Table 121. Q 2 Solutions Company Details
Table 122. Q 2 Solutions Business Overview
Table 123. Q 2 Solutions Decentralized Clinical Trial Solution Product
Table 124. Q 2 Solutions Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 125. Q 2 Solutions Recent Development
Table 126. Advarra Company Details
Table 127. Advarra Business Overview
Table 128. Advarra Decentralized Clinical Trial Solution Product
Table 129. Advarra Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 130. Advarra Recent Development
Table 131. Medrio Company Details
Table 132. Medrio Business Overview
Table 133. Medrio Decentralized Clinical Trial Solution Product
Table 134. Medrio Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 135. Medrio Recent Development
Table 136. Huma Company Details
Table 137. Huma Business Overview
Table 138. Huma Decentralized Clinical Trial Solution Product
Table 139. Huma Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 140. Huma Recent Development
Table 141. THREAD Company Details
Table 142. THREAD Business Overview
Table 143. THREAD Decentralized Clinical Trial Solution Product
Table 144. THREAD Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 145. THREAD Recent Development
Table 146. Cogstate Company Details
Table 147. Cogstate Business Overview
Table 148. Cogstate Decentralized Clinical Trial Solution Product
Table 149. Cogstate Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 150. Cogstate Recent Development
Table 151. Veristat Company Details
Table 152. Veristat Business Overview
Table 153. Veristat Decentralized Clinical Trial Solution Product
Table 154. Veristat Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 155. Veristat Recent Development
Table 156. Clario Company Details
Table 157. Clario Business Overview
Table 158. Clario Decentralized Clinical Trial Solution Product
Table 159. Clario Revenue in Decentralized Clinical Trial Solution Business (2019-2024) & (US$ Million)
Table 160. Clario Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 164. Authors List of This Report
List of Figures
Figure 1. Decentralized Clinical Trial Solution Picture
Figure 2. Global Decentralized Clinical Trial Solution Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Decentralized Clinical Trial Solution Market Share by Type: 2023 VS 2030
Figure 4. Hybrid Clinical Trial Features
Figure 5. Completely Decentralized Clinical Trial Features
Figure 6. Global Decentralized Clinical Trial Solution Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Decentralized Clinical Trial Solution Market Share by Application: 2023 VS 2030
Figure 8. Oncology Case Studies
Figure 9. Cardiovascular Case Studies
Figure 10. Others Case Studies
Figure 11. Decentralized Clinical Trial Solution Report Years Considered
Figure 12. Global Decentralized Clinical Trial Solution Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Decentralized Clinical Trial Solution Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Decentralized Clinical Trial Solution Market Share by Region: 2023 VS 2030
Figure 15. Global Decentralized Clinical Trial Solution Market Share by Players in 2023
Figure 16. Global Top Decentralized Clinical Trial Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trial Solution as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Decentralized Clinical Trial Solution Revenue in 2023
Figure 18. North America Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Decentralized Clinical Trial Solution Market Share by Country (2019-2030)
Figure 20. United States Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Decentralized Clinical Trial Solution Market Share by Country (2019-2030)
Figure 24. Germany Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Decentralized Clinical Trial Solution Market Share by Region (2019-2030)
Figure 32. China Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Decentralized Clinical Trial Solution Market Share by Country (2019-2030)
Figure 40. Mexico Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Decentralized Clinical Trial Solution Market Share by Country (2019-2030)
Figure 44. Turkey Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. UAE Decentralized Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. ICON Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 48. Medpace Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 49. Oracle Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 50. Patheon Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 51. Medidata Solutions Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 52. IQVIA Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 53. Parexel Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 54. PPD Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 55. Science 37 Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 56. Signant Health Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 57. Syneos Health Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 58. Obvio Health Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 59. Fortrea Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 60. ProPharma Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 61. Cloudbyz Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 62. Q 2 Solutions Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 63. Advarra Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 64. Medrio Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 65. Huma Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 66. THREAD Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 67. Cogstate Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 68. Veristat Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 69. Clario Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2019-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
